These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate. Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhäuser J, Rogers PD. Eukaryot Cell; 2008 Jul; 7(7):1180-90. PubMed ID: 18487346 [Abstract] [Full Text] [Related]
24. Investigation of ERG11 gene expression among fluconazole-resistant Candida albicans: first report from an Iranian referral paediatric hospital. Teymuri M, Mamishi S, Pourakbari B, Mahmoudi S, Ashtiani MT, Sadeghi RH, Yadegari MH. Br J Biomed Sci; 2015 Jul; 72(1):28-31. PubMed ID: 25906488 [Abstract] [Full Text] [Related]
25. Analysis of CDR1 and MDR1 Gene Expression and ERG11 Substitutions in Clinical Candida tropicalis Isolates from Alexandria, Egypt. El-Kholy MA, Helaly GF, El Ghazzawi EF, El-Sawaf G, Shawky SM. Braz J Microbiol; 2023 Dec; 54(4):2609-2615. PubMed ID: 37606863 [Abstract] [Full Text] [Related]
26. Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India. Singh A, Singh PK, de Groot T, Kumar A, Mathur P, Tarai B, Sachdeva N, Upadhyaya G, Sarma S, Meis JF, Chowdhary A. J Antimicrob Chemother; 2019 May 01; 74(5):1260-1268. PubMed ID: 30753525 [Abstract] [Full Text] [Related]
29. Detection of antifungal drug-resistant and ERG11 gene mutations among clinical isolates of Candida species isolated from Khartoum, Sudan. Osman Mohamed A, Suliman Mohamed M, Abdelrahman Hussain M, Fatahalrahman Ahmed I. F1000Res; 2020 May 01; 9():1050. PubMed ID: 34035903 [Abstract] [Full Text] [Related]
32. [Analysis of ERG11 gene mutation in Candida albicans]. Wang YB, Wang H, Guo HY, Zhao YZ, Luo SQ. Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov 01; 25(11):1390-3. PubMed ID: 16305963 [Abstract] [Full Text] [Related]
34. Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans. Xiang MJ, Liu JY, Ni PH, Wang S, Shi C, Wei B, Ni YX, Ge HL. FEMS Yeast Res; 2013 Jun 01; 13(4):386-93. PubMed ID: 23480635 [Abstract] [Full Text] [Related]
35. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations. Jensen RH, Astvad KM, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC. J Antimicrob Chemother; 2015 Sep 01; 70(9):2551-5. PubMed ID: 26017038 [Abstract] [Full Text] [Related]
36. Drug resistance genes and trailing growth in Candida albicans isolates. Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA. J Antimicrob Chemother; 2004 Feb 01; 53(2):217-24. PubMed ID: 14688046 [Abstract] [Full Text] [Related]
37. Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait. Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z. Microb Drug Resist; 2017 Dec 01; 23(8):966-972. PubMed ID: 28353392 [Abstract] [Full Text] [Related]
40. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections. Esfahani A, Omran AN, Salehi Z, Shams-Ghahfarokhi M, Ghane M, Eybpoosh S, Razzaghi-Abyaneh M. Microb Pathog; 2022 Sep 01; 170():105696. PubMed ID: 35921954 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]